Fuchu He

Fuchu He (1962–) is a leading scientist in proteomics in China. He was the founder of CNHUPO and among the first group of people who founded HUPO in 2001. He was the first Chinese scientist to lead an international consortium—the Human Liver Proteome Project (HLPP)—and the founder of the Beijing Proteome Research Center, National Center for Protein Sciences (Beijing) (also named as the “Phoenix Center”, an abbreviation for “Pilot Hub Of ENcyclopedia proteomIX”), and Institutes of Biomedical Sciences Fudan University. As the chief scientist, he has been propelling HLPP into the China Human Proteome Project (CNHPP) to create an encyclopedia of proteins in the human body under physiological and pathological conditions. In 2019, his team stratified early Hepatocellular Carcinoma (HCC) into 3 proteomic subtypes with different clinical outcomes. Some drug targetable proteins have been demonstrated to be useful in identifying patients with HCC who could potentially benefit from targeted treatment in further clinical trials. These studies demonstrated proteomic analysis as an independent powerful tool in cancer molecular subtyping, indicating that the era of “Proteomics Driven Precision Medicine (PDPM)” is coming. He is currently leading a worldwide project called π-HuB (The Proteomic Navigator of the Human Body). It aims at playing a central and catalytic role in biomedical research over the next several decades and to providing an ultimate solution at the molecular level for the health and well-being of humankind.